pharma · Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Daihong Liu
Daihong Liu events on NovaPharmaNews — congress presentations and investor conference coverage.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 8
- Patents
- 0
Events
Daihong Liu events on NovaPharmaNews — congress presentations and investor conference coverage.
Daihong Liu events on NovaPharmaNews — congress presentations and investor conference coverage.